|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/47 | (2006.01) |
| A61K 31/517 | (2006.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61P 43/00 | (2006.01) | ||
| G01N 33/574 | (2006.01) | ||
| G01N 33/50 | (2006.01) |
| (11) | Patento numeris | 2281901 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 10015141.4 |
| Europos patento paraiškos padavimo data | 2006-08-02 | |
| (97) | Europos patento paraiškos paskelbimo data | 2011-02-09 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2013-11-27 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 2005224173 | 2005-08-02 | JP | |
| 2006164700 | 2006-06-14 | JP |
| (72) |
Uenaka, Toshimitsu, JP
Yamamoto, Yuji, JP
Matsui, Junji, JP
|
| (73) |
Eisai R&D Management Co., Ltd.,
6-10, Koishikawa 4-chome Bunkyo-ku, Tokyo 112-8088,
JP
|
| (54) | Anti-tumour pharmaceutical composition with angiogenesis inhibitors |
| Anti-tumour pharmaceutical composition with angiogenesis inhibitors |